The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Ceritinib in advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC): Results of the ASCEND-1 trial.
Dong-Wan Kim
Consultant or Advisory Role - Novartis
Ranee Mehra
Employment or Leadership Position - GlaxoSmithKline (I)
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Honoraria - Pfizer
Daniel Shao-Weng Tan
Honoraria - Bayer; Novartis
Research Funding - Novartis
Enriqueta Felip
Consultant or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Roche
Laura Quan Man Chow
Research Funding - University of Washington
D. Ross Camidge
Consultant or Advisory Role - Novartis
Johan F. Vansteenkiste
No relevant relationships to disclose
Sunil Sharma
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Tommaso De Pas
No relevant relationships to disclose
Gregory J. Riely
Consultant or Advisory Role - Abbott Laboratories; ARIAD; Celgene; Chugai Pharma; Daiichi Sankyo; Foundation Medicine; Novartis; Tragara Pharmaceuticals
Research Funding - Chugai Pharma; GlaxoSmithKline; Infinity Pharmaceuticals; Merck; Millennium; Novartis; Pfizer
Benjamin J. Solomon
Consultant or Advisory Role - Novartis; Pfizer; Roche
Juergen Wolf
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Michael Thomas
Consultant or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Novartis; Roche
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Novartis; Roche
Research Funding - Lilly
Martin H. Schuler
Consultant or Advisory Role - Novartis; Pfizer
Honoraria - Novartis
Research Funding - Novartis
Geoffrey Liu
No relevant relationships to disclose
Armando Santoro
Consultant or Advisory Role - Amgen; Bayer; GlaxoSmithKline; Roche; Takeda
Honoraria - ArQule
Margarida Geraldes
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Anthony Boral
Employment or Leadership Position - Novartis Institutes for Biomedical Research
Alejandro Javier Yovine
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Alice Tsang Shaw
Consultant or Advisory Role - ARIAD; Chugai Pharma; Genentech; Novartis; Pfizer